Long-acting injectable cabotegravir/rilpivirine in a pregnant woman living with HIV with hyperemesis gravidarum:a case report and review of literature

Emanuela Lattuada, Andrea Delama, Alessandro Castelli, Giovanni Mori, Daniela Piacentini, Massimiliano Lanzafame, Unit of Infectious Diseases, Santa Chiara Hospital, Azienda Sanitaria Universitaria Integrata Trentina, Unit of Infectious Diseases, San Martino Hospital, Faculty of Medicine, University of Trento

International Journal of STD & AIDS: Clinical practice in sexual health

Published online on June 17, 2026

Abstract

International Journal of STD & AIDS, Volume 37, Issue 9, Page 1055-1058, August 2026.
IntroductionLong-acting injectable cabotegravir/rilpivirine (CAB/RPV LA) represents a novel antiretroviral strategy that bypasses gastrointestinal absorption, potentially advantageous in pregnant individuals unable to tolerate oral therapy. However, its ...